62 related articles for article (PubMed ID: 23510351)
21. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract][Full Text] [Related]
22. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
Ohtsuka Y; Kawakami S; Fujii Y; Koga F; Saito K; Ando N; Takizawa T; Kageyama Y; Kihara K
BJU Int; 2006 Jun; 97(6):1322-6. PubMed ID: 16686732
[TBL] [Abstract][Full Text] [Related]
23. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
24. Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances.
Kwon MJ; Kim DH; Park HR; Shin HS; Kwon JH; Lee DJ; Kim JH; Cho SJ; Nam ES
Hum Pathol; 2014 Jul; 45(7):1327-38. PubMed ID: 24810547
[TBL] [Abstract][Full Text] [Related]
25. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
26. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
Wang X; Jones TD; Maclennan GT; Yang XJ; Lopez-Beltran A; Eble JN; Koch MO; Lin H; Baldridge LA; Tretiakova M; Cheng L
Anticancer Res; 2005; 25(3B):2001-4. PubMed ID: 16158936
[TBL] [Abstract][Full Text] [Related]
27. Prognostic role of integrin β1, E-cadherin, and rac1 expression in small cell lung cancer.
Chang MH; Lee K; Lee KY; Kim YS; Kim YK; Kang JH
APMIS; 2012 Jan; 120(1):28-38. PubMed ID: 22151306
[TBL] [Abstract][Full Text] [Related]
28. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
Gandour-Edwards R; Lara PN; Folkins AK; LaSalle JM; Beckett L; Li Y; Meyers FJ; DeVere-White R
Cancer; 2002 Sep; 95(5):1009-15. PubMed ID: 12209684
[TBL] [Abstract][Full Text] [Related]
29. GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor.
Miyamoto H; Izumi K; Yao JL; Li Y; Yang Q; McMahon LA; Gonzalez-Roibon N; Hicks DG; Tacha D; Netto GJ
Hum Pathol; 2012 Nov; 43(11):2033-40. PubMed ID: 22607700
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of bcl-2, bax, P53 in neuroendocrine carcinomas of the lung].
Shao Y; Zhao P; Li X
Zhongguo Fei Ai Za Zhi; 2006 Feb; 9(1):55-9. PubMed ID: 21144283
[TBL] [Abstract][Full Text] [Related]
33. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
34. c-Src expression is predictive of poor prognosis in breast cancer patients with bone metastasis, but not in patients with visceral metastasis.
Zhang L; Teng Y; Zhang Y; Liu J; Xu L; Qu J; Hou K; Yang X; Liu Y; Qu X
APMIS; 2012 Jul; 120(7):549-57. PubMed ID: 22716210
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
[TBL] [Abstract][Full Text] [Related]
36. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
[TBL] [Abstract][Full Text] [Related]
37. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome.
Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Garraway I; Wong SG; Belldegrun AS; Pantuck AJ
J Urol; 2010 Jun; 183(6):2403-8. PubMed ID: 20403620
[TBL] [Abstract][Full Text] [Related]
38. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
[TBL] [Abstract][Full Text] [Related]
39. Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
Tsai YS; Tzai TS; Chow NH
Urol Int; 2007; 79(3):210-6. PubMed ID: 17940352
[TBL] [Abstract][Full Text] [Related]
40. SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma.
Chuang HW; Hsia KT; Liao JB; Yeh CC; Kuo WT; Yang YF
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]